Moreover, lenalidomide treatment prevented a CXCL12-induced increase in S727-STAT3 phosphorylation in CLL cells over baseline (Figure 9A) and, thus, IL-10 production by CLL cells (Figure 9B). This evidence concerns the gene STAT3 and B-cell chronic lymphocytic leukemia.